Literature DB >> 24480233

Emergency department pericardial drainage for penetrating cardiac wounds is a viable option for stabilization.

Teresa S Jones1, Clay Cothren Burlew2, Robert T Stovall1, Fredric M Pieracci1, Jeffrey L Johnson1, Gregory J Jurkovich1, Ernest E Moore1.   

Abstract

BACKGROUND: Penetrating cardiac injuries (PCI) causing tamponade causes subendocardial ischemia, arrhythmias, and cardiac arrest. Pericardial drainage is an important principle, but where drainage should be performed is debated. We hypothesize that drainage in the emergency department (ED) does not delay definitive repair.
METHODS: Over a 16-year period, patients sustaining PCI were reviewed.
RESULTS: Seventy-eight patients with PCI survived to the operating room (OR), with 39 undergoing ED thoracotomy. An additional 39 patients underwent pericardial drainage, 17 (44%) in the ED and 22 in the OR. Comparing the ED with OR pericardial drainage groups, they had a similar ED systolic pressure (99 ± 25 vs 99 ± 34), heart rate (103 ± 16 vs 85 ± 37), median time to the OR (20 vs 22 min), and mortality (12% vs 23%).
CONCLUSIONS: ED pericardial drainage for PCI did not appear to delay operation and had an acceptably low mortality rate. Pericardial drainage is a viable option for stabilization before definitive surgery when surgical intervention is not immediately available in the hemodynamically marginal patient.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac injury; ED thoracotomy; Penetrating trauma; Pericardial drain; Pericardial tamponade; Trauma

Mesh:

Year:  2014        PMID: 24480233     DOI: 10.1016/j.amjsurg.2013.08.042

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  Pericardiocentesis followed by thoracotomy and repair of penetrating cardiac injury caused by nail gun injury to the heart.

Authors:  Vasu Chirumamilla; Kartik Prabhakaran; Petrone Patrizio; John A Savino; Corrado P Marini; Zobair Zoha
Journal:  Int J Surg Case Rep       Date:  2016-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.